title: Angiotensin II receptor antagonist treatment lowers plasma total and very low + low density lipoprotein cholesterol in Type 1 diabetic patients with albuminuria without affecting plasma cholesterol esterification and cholesteryl ester transfer.
authors.forename: H
authors.initials: H
authors.lastname: Buter
authors.forename: A
authors.initials: A
authors.lastname: van Tol
authors.forename: G J
authors.initials: GJ
authors.lastname: Navis
authors.forename: L M
authors.initials: LM
authors.lastname: Scheek
authors.forename: P E
authors.initials: PE
authors.lastname: de Jong
authors.forename: D
authors.initials: D
authors.lastname: de Zeeuw
authors.forename: R P
authors.initials: RP
authors.lastname: Dullaart
mesh_terms: D000328:Adult; D000419:Albuminuria; D057911:Angiotensin Receptor Antagonists; D002784:Cholesterol / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008875:Middle Aged
chemical_list: D057911:Angiotensin Receptor Antagonists; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D002784:Cholesterol; D019808:Losartan